Related Experiment Video
Updated: May 6, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
24.5K
Pediatric Bullous Pemphigoid Treated With Dupilumab: A Case Report With Good Response
Aldana Belén Almassio1, Laura Luna2, Margarita Larralde1,3
1Pediatric Dermatology Section, Hospital Ramos Mejía, Buenos Aires, Argentina.
Pediatric Dermatology
|May 22, 2025
Summary
Bullous pemphigoid (BP) is a rare blistering disease in children. A 3-year-old girl with treatment-resistant BP achieved remission with dupilumab, suggesting its potential as a safe alternative therapy.
Area of Science:
- Dermatology
- Immunology
- Pediatrics
Background:
- Bullous pemphigoid (BP) is a chronic autoimmune blistering disease primarily affecting older adults.
- Pediatric bullous pemphigoid is rare and presents unique management challenges.
